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ABSTRACT
Streptococcus agalactiae or group B Streptococcus (GBS) is one of the most important causal agents 
of serious neonatal infections. Numerous assays have been evaluated for GBS screening in order to 
validate a fast and efficient method. The aim of this study was to compare the culture technique (es-
tablished as the gold standard) with the molecular method of polymerase chain reaction (PCR) with 
specific primers (atr gene). Two hundred and sixty-three samples were analyzed. Vaginal samples 
were collected, according to the Centers for Disease Control and Prevention (CDC) recommenda-
tions, from women over 35 weeks of pregnancy at Hospital de Clínicas de Porto Alegre (HCPA). 
Two different extraction methods were tested in all samples collected. PCR technique yielded 71 
(26.99%) positive results. Sensitivity and specificity for PCR were 100% and 86.88%, respectively. 
PCR demonstrated a shorter turnaround time than the culture. The molecular methodology proved 
to be a useful screening for GBS, allowing effective treatment to be initiated in shorter time to pre-
vent newborn infection.
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INTRODUCTION
Streptococcus agalactiae, or Lancefield group 
B Streptococcus (GBS), is one of the most im-
portant causal agent of serious infections and 
neonatal sepsis.1-3 As many as 40% of all preg-
nant women present rectal and/or vaginal GBS 
colonization.4 The incidence of neonatal 
GBS infection is 0.5 per 100 live births. Verti-
cal transmission from mother to the neonate 
by either pathway accounts for up to 75% of 
cases of neonatal GBS colonization, and 1% 
to 2% of these infants will develop early-onset 
GBS infection.5,6
Since 2002, the Centers for Disease Con-
trol and Prevention (CDC) recommend GBS 
screening for pregnant women by culture-
based method. This approach is preferable, 
resulting in more effective prevention that 
risk-based chemoprophylaxis (previous CDC 
recommendation).7-9 The standard method 
for the diagnosis of GBS colonization consists 
of culturing combined vaginal and anal swab 
in a selective broth medium that inhibits the 
growth of non-GBS microorganisms. Howev-
er, this method requires at least 48h for fully 
GBS identification. Moreover, negative culture 
results are observed in some women whose 
infants subsequently develop GBS infection.10 
An ideal screening test for GBS coloniza-
tion is which could accurately identify preg-
nant women who carry the bacteria (even 
low-count bacteria carriers) and presenting a 
short turnaround time. Many techniques have 
been tested in order to validate a fast and ef-
ficient method of GBS screening to replace 
the culture.11-13 Nowadays, molecular biology 
based assays, such as PCR (polymerase chain 
reaction) tests, have become the focus of in-
vestigation of detection of GBS colonization 
in pregnant women.14,15 In these tests, samples 
preparation and amplification targets are de-
cisive to performance assay. A good target for 
GBS amplification is the atr gene because it is 
well studied in this species. Moreover, the atr 
is an essential gene, which means that it has to 
be expressed/present in all cells of this species. 
The gene encodes a protein amino acid trans-
porter gs0538 which is extremely specific to 
S. agalactiae species. Because it is a housekeeping 
gene, probability of mutations in atr is compar-
atively rather low.16,17
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The aim of study was compare this atr gene PCR with 
the gold standard (culture-based method) to evaluate the 
PCR performance as GBS colonization screening in preg-
nant women. Additionally, we tested two different extrac-
tion methods to amplify atr gene: a commercial kit and 
thermal lysis protocol, searching more cost-effective mo-
lecular tests.
MATERIALS AND METHODS
Samples
Combined rectal/vaginal specimens were collected to con-
duct this study according to the CDC recommendations.10 
Samples collected were sent to the laboratory for microbiol-
ogy and molecular tests for group B Streptococcus identifi-
cation. We analyzed 263 samples of women at 35 or more 
weeks of pregnancy, in labor or not, attending the emer-
gency obstetric room at Hospital de Clínicas de Porto Alegre 
(HCPA) from September 2007 to September 2008. 
Microbiology tests
The swabs were inoculated into Todd Hewitt (Himedia 
Laboratories, India) selective medium supplemented with 
gentamicin (8 μg/mL) and nalidixic acid (15 μg/mL). The 
selective medium was incubated at 36°C in 5% CO2 for 18h, 
and then subcultured onto blood agar plates (BioMérieux, 
Marcy l`Étoile, France), which were incubated at 36°C in 
5% CO2 for 24h. After incubation the plates were inspected 
for β-hemolytic colonies. When no β-hemolytic colonies 
were observed after 24h, plates were reincubated for an-
other 24h and inspected again. The β-hemolytic colonies 
whose morphology was consistent with group B Streptococ-
cus were subcultured in broth and submitted to the CAMP 
(Christie, Atkins, Munch, Petersen) test. The colonies posi-
tive for the CAMP test were presumptively considered GBS.
Polymerase chain reaction (PCR)
Sample preparation and DNA extraction
The swabs were incubated for 15 to 18h into Todd Hewitt 
selective medium. After centrifugation of broth, the precip-
itate was washed with 1X PBS solution and resuspended in 
TE buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 7.5). This 
solution was submitted to two different DNA extraction 
protocols: thermal lysis and thermal lysis followed by silica 
DNA extraction by commercial kit. 
The thermal lysis was performed using TE solution for 
10 min at 100°C to lyse bacterial cell wall.18 The second 
DNA extraction protocol was performed using the com-
mercial kit QIAmp (Qiagen, Valencia, USA), according to 
manufacturers instructions. This additional step in DNA 
extraction was conducted for ensuring the PCR inhibitors 
elimination. 
Polymerase chain reaction (PCR) gene atr
For the PCR reaction we used the atr primers 5’-
CAA CGA TTC TCT CAG CTT TGT TAA-3’ and 
5’-TAA GAA ATC TCT TGT GCG GAT TTC-3’, 
producing a 780-bp fragment that is specific for the 
gene atr.19 The amplified PCR product of one clinical 
isolate was sequenced and the atr sequence obtained was 
compared in GenBank using the Basic Local Alignment 
Search Tool (BLAST) of National Center for Biotechnol-
ogy Information, Bethesda, MD (http://www.ncbi.nlm.
nih.gov/BLAST/). This isolate sample was used as a pos-
itive control in all PCR reactions.
The volume of reaction was 25 μL and was pre-
pared as follows: 67 mM Tris-HCl, 16 mM (NH4)2SO4, 
0.01% (w/w) Tween-20 (pH 8.8 at 25°C), 1.5 mM MgCl2, 
0.25 mM dNTP (ABgene®, Epson, UK), 0.4 mM of each 
primer, 1.25 U of enzyme Super-Term DNA polymerase 
(JMR Holdings, London, UK) and 5 μL of each DNA 
sample. The amplification was performed with an initial 
denaturation at 94°C for 1 min followed by 30 cycles of 
1 min at 94°C, 45 s at 55°C for primer annealing, 1 min 
at 72°C for elongation and a final period of extension at 
72°C for 10 min.
The amplification products were detected by electro-
phoresis using 10 μL of the amplified reaction mixture 
in agarose gel 2%, containing 0.4 mg/mL ethidium bro-
mide. Visualization was performed with ultraviolet light 
transilluminator. A 100-bp molecular weight marker 
(Invitrogen®, Calbad, USA) and a positive control of 
S. agalactiae were used to evaluate the PCR products. 
The samples presenting a 780-bp amplicon were consid-
ered positive for GBS. 
Statistical analysis
Sensitivity, specificity, PPV and NPV were calculated 
for the PCR technique using culture as gold standard.
The concordance between assays was determined using 
the Kappa coefficient. The statistical analysis was per-
formed in SPSS® version 14.0.
RESULTS 
In the molecular method, all samples were tested with 
both DNA extractions (thermal lysis only and thermal 
lysis + Qiagen extraction) before PCR reaction. We 
observed four discrepancies (4/263) between the two 
methods. PCR reactions with and without Qiagen ex-
tractions were compared, yielding a Kappa of 0.961, 
which indicates excellent agreement.20 Thus, the PCR 
method was used inrespective of the process of DNA 
extraction used.
Altogether, the culture method turned out positive 
in 42 (15.96%) samples, while the PCR technique was 
GBS detection: comparison of molecular and culture methods
BJID-4-JUN ARTE FINAL.indd   324 28/07/11   13:30
325
positive in 71 (26.99%) (Table 1). All culture-positive 
samples were also positive with the PCR technique, 
therefore resulting in 100% PCR sensitivity (95% CI: 
91.62-100). Of the 221 culture-negative samples for 
GBS, 29 were positive with PCR and 192 were nega-
tive with both methods, which indicate a specificity of 
82.6% (95% CI: 81.79-90.71) of the molecular method. 
The negative predictive value was 100% and positive 
predictive value was 59% (Figure 1). The agreement be-
yond chance (Kappa) between the techniques was 0.68, 
indicating substantial agreement.20
DISCUSSION
Despite CDC recommendations to use culture as GBS 
screening in pregnant women, many routine clinical situ-
ations require a faster and more efficient method than 
culture.11-13 Therefore, this study reports results for two 
different extraction protocols and the use of atr gene as 
amplification target by PCR and its potential use as GBS 
screening test. Thermal lysis is the cheapest extraction 
method and has good performance for this samples when 
compared to the Qiagen kit. This extraction protocol could 
present the best cost-effectiveness ratio when applied in 
clinical laboratory routine.
GBS colonization rates were 15.96% using the cul-
ture and 26.99% using PCR. In Brazil, the GBS coloniza-
tion rate was estimated by Borger and co-workers to be 
between 15% to 25%. However, the prevalence of GBS 
colonization could vary widely with geographic location, 
age, parity and socio-economic status.21 Furthermore, a 
review conducted in 1998 on the prevalence of coloniza-
tion by GBS in developing countries suggested that coloni-
zation rates may be underestimated in many studies due to 
inadequate culture techniques employed.22 Recent Brazil-
ian studies using PCR to detect GBS have reported 21.6% 
Table 1. Comparison of PCR and Todd Hewitt culture 
medium results
PCR                    Culture  Total
 Positive Negative 
Positive 42 29 71
Negative 0 192 192
Total 42 221 263
Samples
(n = 263)
Positive culture
(n = 42)
Positive PCR
(n = 42)
Sensitivity
100% (42/42)
Specificity
86.88% 
(192/221)
Positive predictive 
value
59% (42/71)
Negative predictive 
value
100% (192/192)
Positive PCR
(n = 29)
Negative PCR
(n = 0)
Negative PCR
(n = 192)
Negative culture
(n = 221)
Figure 1: Diagram of sensitivity, specificity and predictive values of identifying the GBS presence in pregnant women by PCR assay.
de-Paris, Machado, Gheno et al.
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and 20.4% as colonization rates.7,21 These rates are very 
similar to those observed in this study. 
Great sensitivity, high negative predictive value and rap-
id results are desirable parameters of a screening test. In our 
study, the sensitivity of PCR was 100%, higher than the value 
observed in similar studies conducted by Gavino & Wang15 
and Alfa23, where the sensitivity was 95.8% and 90.5%, re-
spectively. Probably, the high sensibility is due to use of se-
lective and enriched broth previous to performing the PCR. 
The negative predictive value was 100%. This finding is im-
portant because it indicates that all samples with negative 
results are truly negative, which affords to safely withhold 
treatment from women presenting PCR negative samples. 
This is so important in clinical routine because false negative 
results in a screening test may lead to serious consequences 
for the patient, considering that this test is used to take a 
decision about antibiotic prophylaxis.
The specificity found was 86.88%, greater than the 64.5% 
found by Gavino & Wang.15 However, even being considered 
the gold standard, culture results can be false negative. It is 
known that culture may not be absolutely effective in the 
detection of GBS, since other bacteria of the vaginal/genital 
tract can inhibit the growth of GBS even when using the se-
lective broth. So, the supposedly false positive results in PCR 
may actually indicate the presence of GBS in the studied ma-
terial, since this is an analytical technique whose sensitivity 
could be greater than the bacteriological examination. The 
gold standard performance affects the positive predictive 
value parameter. Consequently, in our study the positive 
predictive value was 59%. 
Moreover, the culture is a time-consuming method requir-
ing at least 48h for fully GBS identification. The PCR proposed 
in this study, even using a previous incubation in selective 
broth, requires 24h to give the final result. Therefore, GBS PCR 
has a considerable shorter turnaround time than the culture.
In summary, since the publication of the Guidelines 
of GBS colonization by the CDC in 2002, the incidence of 
neonatal infections decreased by more than 60%. The use of 
new techniques with higher accuracy and faster results for 
detection of this microorganism could contribute even fur-
ther to this improvement.2 Accordingly, our study indicates 
that the PCR technique has proven to have high sensitivity, 
and that it should be a useful screening method. Such meth-
odology can be a diagnostic tool for GBS, allowing effective 
treatment and decreasing newborn morbidity and mortality. 
In this scenario, cost-effectiveness studies are necessary to 
assess the feasibility of implementing this method as a rou-
tine in centers with maternity wards.
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